MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.amepre.2016.03.017

Медицинская библиотека · American journal of preventive medicine · 2016

Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/Ethnicity.

McCarthy Anne Marie, Kim Jane J, Beaber Elisabeth F, Zheng Yingye, Burnett-Hartman Andrea, Chubak Jessica, Ghai Nirupa R, McLerran Dale, Breen Nancy, Conant Emily F, Geller Berta M, Green Beverly B, Klabunde Carrie N, Inrig Stephen, Skinner Celette Sugg, Quinn Virginia P, Haas Jennifer S, Schnall Mitchell, Rutter Carolyn M, Barlow William E, Corley Douglas A, Armstrong Katrina, Doubeni Chyke A, PROSPR consortium

СтатьяПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

INTRODUCTION

Timely follow-up of abnormal tests is critical to the effectiveness of cancer screening, but may vary by screening test, healthcare system, and sociodemographic group.

METHODS

Timely follow-up of abnormal mammogram and fecal occult blood testing or fecal immunochemical tests (FOBT/FIT) were compared by race/ethnicity using Population-Based Research Optimizing Screening through Personalized Regimens consortium data. Participants were women with an abnormal mammogram (aged 40-75 years) or FOBT/FIT (aged 50-75 years) in 2010-2012. Analyses were performed in 2015. Timely follow-up was defined as colonoscopy ≤3 months following positive FOBT/FIT; additional imaging or biopsy ≤3 months following Breast Imaging Reporting and Data System Category 0, 4, or 5 mammograms; or ≤9 months following Category 3 mammograms. Logistic regression was used to model receipt of timely follow-up adjusting for study site, age, year, insurance, and income.

RESULTS

Among 166,602 mammograms, 10.7% were abnormal; among 566,781 FOBT/FITs, 4.3% were abnormal. Nearly 96% of patients with abnormal mammograms received timely follow-up versus 68% with abnormal FOBT/FIT. There was greater variability in receipt of follow-up across healthcare systems for positive FOBT/FIT than for abnormal mammograms. For mammography, black women were less likely than whites to receive timely follow-up (91.8% vs 96.0%, OR=0.71, 95% CI=0.51, 0.97). For FOBT/FIT, Hispanics were more likely than whites to receive timely follow-up than whites (70.0% vs 67.6%, OR=1.12, 95% CI=1.04, 1.21).

CONCLUSIONS

Timely follow-up among women was more likely for abnormal mammograms than FOBT/FITs, with small variations in follow-up rates by race/ethnicity and larger variation across healthcare systems.

Для цитирования: McCarthy Anne Marie, Kim Jane J, Beaber Elisabeth F, Zheng Yingye, Burnett-Hartman Andrea, Chubak Jessica, Ghai Nirupa R, McLerran Dale, Breen Nancy, Conant Emily F, Geller Berta M, Green Beverly B, Klabunde Carrie N, Inrig Stephen, Skinner Celette Sugg, Quinn Virginia P, Haas Jennifer S, Schnall Mitchell, Rutter Carolyn M, Barlow William E, Corley Douglas A, Armstrong Katrina, Doubeni Chyke A, PROSPR consortium. Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/Ethnicity.. American journal of preventive medicine. 2016. DOI: 10.1016/j.amepre.2016.03.017.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.